{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["anti-microbial", "anti-viral", "hyaluronic acid", "liposome", "nanobubble", "ozone"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "35115773", "DateCompleted": {"Year": "2022", "Month": "02", "Day": "07"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "30"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2022", "Month": "01", "Day": "25"}], "ELocationID": ["10.2147/IJN.S328090"], "Journal": {"ISSN": "1178-2013", "JournalIssue": {"Volume": "17", "PubDate": {"Year": "2022"}}, "Title": "International journal of nanomedicine", "ISOAbbreviation": "Int J Nanomedicine"}, "ArticleTitle": "Nanobubble Ozone Stored in Hyaluronic Acid Decorated Liposomes: Antibacterial, Anti-SARS-CoV-2 Effect and Biocompatibility Tests.", "Pagination": {"StartPage": "351", "EndPage": "379", "MedlinePgn": "351-379"}, "Abstract": {"AbstractText": ["SARS-CoV-2-infected individuals may be asymptomatic, and therefore, the virus is highly contagious. We aimed to develop an agent to control viral replication in the upper respiratory tract and to prevent progression of the disease into the lower airways as well as inter-individual transmission. For this purpose, we investigated the antibacterial and antiviral activities of our novel nanobubble ozonated hyaluronic acid-decorated liposomal (NOHAL) solution, developed by using nanotechnology.", "The MIC levels of NOHAL solution were determined on blood agar cultures of <i>Staphylococcus aureus</i> (ATCC 6538), <i>Streptococcus</i> <i>pneumoniae</i> (ATCC 49619) and <i>Escherichia coli</i> (ATCC 25922). The in vitro anti-viral activity of NOHAL solution was studied using recombinant SARS-CoV-2 copies of the original virus, grown in Vero cells generated by reverse genetic technology. Human primary lung epithelial cells obtained by bronchoscopy or lung resection were used for cell viability tests using flow cytometry analysis. The cytotoxicity testing was performed using the BALB/c 3T3 (CCL-163) cell line. Skin, oral, nasal and ocular irritation tests were performed using New Zealand albino rabbits, Syrian hamsters, BALB c mice and New Zealand albino rabbits of both sexes.", "Bacterial growth was prevented by NOHAL solution in a time-/dose-dependent manner. In vivo or in vitro experiments did not show any toxicity of NOHAL solution. No cytotoxicity was recorded on cell viability. No skin, oral, nasal or ocular toxicities were recorded. In addition, in a SARS-CoV-2 mouse infection model, NOHAL solution diminished the viral RNA levels effectively in nasopharyngeal and lung samples after its prophylactic intranasal application.", "NOHAL solution has the potential to reduce or prevent the spread of SARS-CoV-2 through the nose and/or oral cavity. The clinical efficacy of this solution needs to be tested in order to determine its efficacy in the early phase of COVID-19."], "CopyrightInformation": "\u00a9 2022 Sabanc\u0131 et al."}, "AuthorList": [{"Identifier": ["0000-0003-3538-7762"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bursa \u00c7ekirge State Hospital, Orthopedics and Traumatology Clinic, Bursa, Turkey."}], "LastName": "Sabanc\u0131", "ForeName": "Ahmet Umit", "Initials": "AU"}, {"Identifier": ["0000-0002-8837-3375"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bursa Uluda\u011f University, Vocational School of Health Services, Medical Laboratory Technician Department, Bursa, Turkey."}], "LastName": "Erkan Alkan", "ForeName": "Perihan", "Initials": "P"}, {"Identifier": ["0000-0002-7563-2948"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "\u00c7ukurova University AGENTEM (Adana Genetic Diseases and Treatment Center), Adana, Turkey."}], "LastName": "Mujde", "ForeName": "Cem", "Initials": "C"}, {"Identifier": ["0000-0001-8424-6849"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "TUBITAK, Marmara Research Center, Genetic Engineering and Biotechnology Institute, Gebze, Kocaeli, Turkey."}], "LastName": "Polat", "ForeName": "Hivda Ulbe\u011fi", "Initials": "HU"}, {"Identifier": ["0000-0002-5932-4259"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bursa Uludag University, Institute of Health Sciences, Department of Translational Medicine, Bursa, Turkey."}], "LastName": "Ornek Erguzeloglu", "ForeName": "Cemre", "Initials": "C"}, {"Identifier": ["0000-0002-2053-9076"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "\u00c7ukurova University AGENTEM (Adana Genetic Diseases and Treatment Center), Adana, Turkey."}, {"Identifier": [], "Affiliation": "\u00c7ukurova University, Faculty of Medicine, Department of Medical Genetics, Adana, Turkey."}], "LastName": "Bisgin", "ForeName": "Atil", "Initials": "A"}, {"Identifier": ["0000-0001-5428-3630"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bursa Uluda\u011f University, Faculty of Medicine, Department of Infectious Diseases and Microbiology, Bursa, Turkey."}], "LastName": "Ozakin", "ForeName": "Cuneyt", "Initials": "C"}, {"Identifier": ["0000-0002-9802-0880"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bursa Uludag University, Institute of Health Sciences, Department of Translational Medicine, Bursa, Turkey."}, {"Identifier": [], "Affiliation": "Bursa Uluda\u011f University, Faculty of Medicine, Department of Medical Genetics, Bursa, Turkey."}, {"Identifier": [], "Affiliation": "Bursa Uludag University, Health Sciences Institute, Department of Translational Medicine, Bursa, Turkey."}], "LastName": "Temel", "ForeName": "Sehime G", "Initials": "SG"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "New Zealand", "MedlineTA": "Int J Nanomedicine", "NlmUniqueID": "101263847", "ISSNLinking": "1176-9114"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Bacterial Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Liposomes"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "9004-61-9", "NameOfSubstance": "Hyaluronic Acid"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Anti-Bacterial Agents"}, {"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "Chlorocebus aethiops"}, {"QualifierName": [], "DescriptorName": "Cricetinae"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Hyaluronic Acid"}, {"QualifierName": [], "DescriptorName": "Liposomes"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Rabbits"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "Vero Cells"}], "CoiStatement": "Dr. Ahmet Umit SABANCI is the founder of SONOFARMA Pharmaceutical Chemicals Industry and Trade Inc. and has a financial interest in the company. Dr. Ahmet \u00dcmit SABANCI reports a patent WO2019240713A2 pending to World, a patent WO2019240713A3 pending to World, a patent US2021007360A1 pending to USA, a patent TR201904790A pending to Turkey, a patent TR2021-00105 pending to Turkey. The authors report no other conflicts of interest in this work."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ratz-lyko A, Arct J, Pytkowska K. Moisturizing and anti-inflammatory properties of cosmetic formulations containing Centella Asiatica extract. Indian J Pharm Sci. 2016;78(1):27. doi:10.4103/0250-474X.180247", "ArticleIdList": ["10.4103/0250-474X.180247", "PMC4852572", "27168678"]}, {"Citation": "M. Nabil Mawsouf, M.M. El-Sawalhi,G. Mart\u00ednez-S\u00e1nchez, H.A. Darwish,A.A. Shaheen, L. Re. Effect of ozone therapy on redox status in experimentally induced arthritis. Int J Ozone Ther. 2010;9(1):7\u201313."}, {"Citation": "Bocci V. OZONE a New Medical Drug. Softcover reprint of hardcover. 1st ed. Springer; 2010."}, {"Citation": "Seyman D, Ozen NS, Inan D, Ongut G, Ogunc D. Pseudomonas aeruginosa septic arthritis of knee after intra-articular ozone injection. New Microbiol. 2012;35(3):345\u2013348.", "ArticleIdList": ["22842605"]}, {"Citation": "Zheng Z, Dong M, Hu K. A preliminary evaluation on the efficacy of ozone therapy in the treatment of COVID\u201019. J Med Virol. 2020;92(11):2348\u20132350. doi:10.1002/jmv.26040", "ArticleIdList": ["10.1002/jmv.26040", "PMC7280732", "32437014"]}, {"Citation": "Rowen RJ, Robins H. Ozone therapy for complex regional pain syndrome: review and case report. Curr Pain Headache Rep. 2019;23(6):41. doi:10.1007/s11916-019-0776-y", "ArticleIdList": ["10.1007/s11916-019-0776-y", "PMC6502773", "31062104"]}, {"Citation": "Seydanur Dengizek E, Serkan D, Abubekir E, Aysun Bay K, Onder O, Arife C. Evaluating clinical and laboratory effects of ozone in non-surgical periodontal treatment: a randomized controlled trial. J Appl Oral Sci. 2019;27:1\u20138. doi:10.1590/1678-7757-2018-0108", "ArticleIdList": ["10.1590/1678-7757-2018-0108", "PMC6438664", "30673028"]}, {"Citation": "Sconza C, Respizzi S, Virelli L, et al. Oxygen\u2013ozone therapy for the treatment of knee osteoarthritis: a systematic review of randomized controlled trials. Arthroscopy. 2020;36(1):277\u2013286. doi:10.1016/j.arthro.2019.05.043", "ArticleIdList": ["10.1016/j.arthro.2019.05.043", "31679646"]}, {"Citation": "Fern\u00e1ndez-Cuadros ME. Ozone Fundamentals and Effectiveness on Knee Pain: Chondromalacia and Knee Osteoarthritis. LAP LAMBERT Academic Publishing; 2016."}, {"Citation": "Fern\u00e1ndez-Cuadros ME, P\u00e9rez-Moro OS, Albaladejo-Florin MJ, Alava-Rabasa S. El ozono intraarticular modula la inflamaci\u00f3n, mejora el dolor, la rigidez, la funci\u00f3n y tiene un efecto anab\u00f3lico sobre la artrosis de rodilla: estudio cuasi-experimental prospectivo tipo antes-despu\u00e9s, 115 pacientes. Revista de La Sociedad Espa\u00f1ola Del Dolor. 2020;27:78\u201386. doi:10.20986/resed.2020.3775/2019", "ArticleIdList": ["10.20986/resed.2020.3775/2019"]}, {"Citation": "Alkan PE, G\u00fcne\u015f M, \u00d6zakin C, Sabanci A. New antibacterial agent: nanobubble ozone stored in liposomes: the antibacterial activity of nanobubble ozone in liposomes and their thymol solutions. Ozone Sci Eng. 2021;1\u20135. doi:10.1080/01919512.2021.1904205", "ArticleIdList": ["10.1080/01919512.2021.1904205"]}, {"Citation": "Monzillo V, Lallitto F, Russo A, et al. Ozonized gel against four candida species: a pilot study and clinical perspectives. Materials. 2020;13(7):1731. doi:10.3390/ma13071731", "ArticleIdList": ["10.3390/ma13071731", "PMC7178640", "32276304"]}, {"Citation": "Jakab GJ, Hmieleski RR. Reduction of influenza virus pathogenesis by exposure to 0.5 ppm ozone. J Toxicol Environ Health. 1988;23(4):455\u2013472. doi:10.1080/15287398809531128", "ArticleIdList": ["10.1080/15287398809531128", "3361616"]}, {"Citation": "Finch GR, Black EK, Labatiuk CW, Gy\u00fcr\u00e9k L, Belosevic M. Comparison of Giardia lamblia and Giardia muris cyst inactivation by ozone. Appl Environ Microbiol. 1993;59(11):3674\u20133680. doi:10.1128/aem.59.11.3674-3680.1993", "ArticleIdList": ["10.1128/aem.59.11.3674-3680.1993", "PMC182516", "8285675"]}, {"Citation": "Criegee R. Mechanism of Ozonolysis. Angew Chem Int Ed Engl. 1975;14(11):745\u2013752. doi:10.1002/anie.197507451", "ArticleIdList": ["10.1002/anie.197507451"]}, {"Citation": "Song M, Zeng Q, Xiang Y, et al. The antibacterial effect of topical ozone on the treatment of MRSA skin infection. Mol Med Rep. 2017;17:2449\u20132455. doi:10.3892/mmr.2017.8148", "ArticleIdList": ["10.3892/mmr.2017.8148", "PMC5783482", "29207120"]}, {"Citation": "Russo T, Curr\u00f2 M, Ferlazzo N, et al. Stable ozonides with vitamin E acetate versus corticosteroid in the treatment of lichen sclerosus in foreskin: evaluation of effects on inflammation. Urol Int. 2019;103(4):459\u2013465. doi:10.1159/000499846", "ArticleIdList": ["10.1159/000499846", "30991399"]}, {"Citation": "Xiao W, Tang H, Wu M, et al. Ozone oil promotes wound healing by increasing the migration of fibroblasts via PI3K/Akt/mTOR signaling pathway. Biosci Rep. 2017;37(6):1\u20139. doi:10.1042/BSR20170658", "ArticleIdList": ["10.1042/BSR20170658", "PMC5678031", "28864782"]}, {"Citation": "Murata T, Komoto S, Iwahori S, et al. Reduction of severe acute respiratory syndrome coronavirus\u20102 infectivity by admissible concentration of ozone gas and water. Microbiol Immunol. 2020;65(1):10\u201316. doi:10.1111/1348-0421.12861", "ArticleIdList": ["10.1111/1348-0421.12861", "PMC7753712", "33230863"]}, {"Citation": "Franzini M, Valdenassi L, Ricevuti G, et al. Oxygen-ozone (O2-O3) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported. Int Immunopharmacol. 2020;88:106879. doi:10.1016/j.intimp.2020.106879", "ArticleIdList": ["10.1016/j.intimp.2020.106879", "PMC7414302", "32795898"]}, {"Citation": "Hern\u00e1ndez A, Vi\u00f1als M, Pablos A, et al. Ozone therapy for patients with COVID-19 pneumonia: preliminary report of a prospective case-control study. Int Immunopharmacol. 2021;90:107261. doi:10.1016/j.intimp.2020.107261", "ArticleIdList": ["10.1016/j.intimp.2020.107261", "PMC7833586", "33310665"]}, {"Citation": "Tascini C, Sermann G, Pagotto A, et al. Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience. Intern Emerg Med. 2020;16(3):669\u2013675. doi:10.1007/s11739-020-02542-6", "ArticleIdList": ["10.1007/s11739-020-02542-6", "PMC7603641", "33131033"]}, {"Citation": "Fern\u00e1ndez-Cuadros ME, Albaladejo-Flor\u00edn MJ, \u00c1lava-rabasa S, et al. Effect of rectal ozone (O3) in severe COVID-19 pneumonia: preliminary results. SN Compr Clin Med. 2020;2(9):1328\u20131336. doi:10.1007/s42399-020-00374-1", "ArticleIdList": ["10.1007/s42399-020-00374-1", "PMC7397966", "32838181"]}, {"Citation": "Bateman RM, Sharpe MD, Ellis CG. Bench-to-bedside review: microvascular dysfunction in sepsis \u2013 hemodynamics, oxygen transport, and nitric oxide. Crit Care. 2003;7(5):359\u2013373. doi:10.1186/cc2353", "ArticleIdList": ["10.1186/cc2353", "PMC270719", "12974969"]}, {"Citation": "Giunta R, Coppola A, Luongo C, et al. Ozonized autohemotransfusion improves hemorheological parameters and oxygen delivery to tissues in patients with peripheral occlusive arterial disease. Ann Hematol. 2001;80:745\u2013748. doi:10.1007/s002770100377", "ArticleIdList": ["10.1007/s002770100377", "11797116"]}, {"Citation": "Wu XN, Zhang T, Wang J, et al. Magnetic resonance diffusion tensor imaging following major ozonated autohemotherapy for treatment of acute cerebral infarction. Neural Regen Res. 2016;11(7):1115\u20131121. doi:10.4103/1673-5374.187046", "ArticleIdList": ["10.4103/1673-5374.187046", "PMC4994454", "27630695"]}, {"Citation": "Borroto RV, Lima HLB, Lima GS, et al. Prevention of the stroke with the application of ozone therapy. Rev Cub Med Fis Rehab. 2013;5(1):3\u201316."}, {"Citation": "Pandolfi S, Zammitti A, Franzini M, et al. Effects of oxygen ozone therapy on cardiac function in a patient with a prior myocardial infarction. Ozone Ther. 2017;2(1). doi:10.4081/ozone.2017.6745", "ArticleIdList": ["10.4081/ozone.2017.6745"]}, {"Citation": "Clavo B, Suarez G, Aguilar Y, et al. Brain ischemia and hypometabolism treated by ozone therapy. Forsch Komplementmed. 2011;18(5):283\u2013287. doi:10.1159/000333795", "ArticleIdList": ["10.1159/000333795", "22105041"]}, {"Citation": "Kekez MM, Sattar SA. A new ozone-based method for virus inactivation: preliminary study. Phys Med Biol. 1997;42:2027\u20132039. doi:10.1088/0031-9155/42/11/002", "ArticleIdList": ["10.1088/0031-9155/42/11/002", "9394395"]}, {"Citation": "Shin GA, Sobsey MD. Reduction of Norwalk virus, poliovirus 1, and bacteriophage MS2 by ozone disinfection of water. Appl Environ Microbiol. 2003;69:3975\u20133978. doi:10.1128/AEM.69.7.3975-3978.2003", "ArticleIdList": ["10.1128/AEM.69.7.3975-3978.2003", "PMC165156", "12839770"]}, {"Citation": "Herbold K, Flehmig B, Botzenhart K. Comparison of ozone inactivation, in flowing water, of hepatitis A virus, poliovirus 1, and indicator organisms. Appl Environ Microbiol. 1989;55:2949\u20132953. doi:10.1128/aem.55.11.2949-2953.1989", "ArticleIdList": ["10.1128/aem.55.11.2949-2953.1989", "PMC203196", "2560362"]}, {"Citation": "Katzenelson E, Koerner G, Biedermann N, Peleg M, Shuval HI. Measurement of the inactivation kinetics of polio virus by ozone in a fast-flow mixer. Appl Environ Microbiol. 1979;37:715\u2013718. doi:10.1128/aem.37.4.715-718.1979", "ArticleIdList": ["10.1128/aem.37.4.715-718.1979", "PMC243286", "36847"]}, {"Citation": "Roy D, Wong PK, Engelbrecht RS, Chian ES. Mechanism of enteroviral inactivation by ozone. Appl Environ Microbiol. 1981;41:718\u2013723. doi:10.1128/aem.41.3.718-723.1981", "ArticleIdList": ["10.1128/aem.41.3.718-723.1981", "PMC243766", "6261692"]}, {"Citation": "Rowen RJ, Robins H. A plausible \u201cPenny\u201d costing effective treatment for corona virus - ozone therapy. J Infect Dis Epidemiol. 2020;6(2):1\u20135."}, {"Citation": "Mirazimi A, Mousavi-Jazi M, Sundqvist VA, Svensson L. Free thiol groups are essential for infectivity of human cytomegalovirus. J Gen Virol. 1999;80:2861\u20132865. doi:10.1099/0022-1317-80-11-2861", "ArticleIdList": ["10.1099/0022-1317-80-11-2861", "10580047"]}, {"Citation": "Markovic I, Stantchev TS, Fields KH, et al. Thiol/disulfide exchange is a prerequisite for CXCR4-tropic HIV-1 envelope-mediated T-cell fusion during viral entry. Blood. 2004;103:1586\u20131594. doi:10.1182/blood-2003-05-1390", "ArticleIdList": ["10.1182/blood-2003-05-1390", "14592831"]}, {"Citation": "Lee JE, Saphire EO. Ebolavirus glycoprotein structure and mechanism of entry. Future Virol. 2009;4:621\u2013635. doi:10.2217/fvl.09.56", "ArticleIdList": ["10.2217/fvl.09.56", "PMC2829775", "20198110"]}, {"Citation": "Madu IG, Belouzard S, Whittaker GR. SARS-coronavirus spike S2 domain flanked by cysteine residues C822 and C833 is important for activation of membrane fusion. Virology. 2009;393(2):265\u2013271. doi:10.1016/j.virol.2009.07.038", "ArticleIdList": ["10.1016/j.virol.2009.07.038", "PMC3594805", "19717178"]}, {"Citation": "Pandey A, Nikam AN, Mutalik SP, et al. Architectured therapeutic and diagnostic nanoplatforms for combating SARS-CoV-2: role of inorganic, organic, and radioactive materials. ACS Biomater Sci Eng. 2020;7(1):31\u201354. doi:10.1021/acsbiomaterials.0c01243", "ArticleIdList": ["10.1021/acsbiomaterials.0c01243", "33371667"]}, {"Citation": "Koo H, Huh MS, Sun IC, et al. In vivo targeted delivery of nanoparticles for theranosis. Acc Chem Res. 2011;44(10):1018\u20131028. doi:10.1021/ar2000138", "ArticleIdList": ["10.1021/ar2000138", "21851104"]}, {"Citation": "Abo-zeid Y, Urbanowicz RA, Thomson BJ, Irving WL, Tarr AW, Garnett MC. Enhanced nanoparticle uptake into virus infected cells: could nanoparticles be useful in antiviral therapy? Int J Pharm. 2018;547(1\u20132):572\u2013581. doi:10.1016/j.ijpharm.2018.06.027", "ArticleIdList": ["10.1016/j.ijpharm.2018.06.027", "29908332"]}, {"Citation": "Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. CLSI standart M07. 11th ed. Wayne,PA: Clinical and Laboratory Standards Institute; 2018."}, {"Citation": "Xie X, Muruato A, Lokugamage KG, et al. An infectious cDNA clone of SARS-CoV-2. Cell Host Microbe. 2020;27(5):841\u2013848.e3. doi:10.1016/j.chom.2020.04.004", "ArticleIdList": ["10.1016/j.chom.2020.04.004", "PMC7153529", "32289263"]}, {"Citation": "Alkan PE, G\u00fcne\u015f ME, \u00d6zakin C, Sabanci A\u00dc. New antibacterial agent: nanobubble ozone stored in liposomes: the antibacterial activity of nanobubble ozone in liposomes and their thymol solutions. Ozone Sci Eng. 2021;43(6):637\u2013641. doi:10.1080/01919512.2021.1904205", "ArticleIdList": ["10.1080/01919512.2021.1904205"]}, {"Citation": "Erkan-Alkan P, G\u00fcne\u015f ME, \u00d6zak\u0131n C, Sabanc\u0131 A\u00dc. [Nanoparticle liposomes: a new strategy in bacterial infections]. Klimik Derg. 2021;34(2):99\u2013102. Turkish. doi:10.36519/kd.2021.3633", "ArticleIdList": ["10.36519/kd.2021.3633"]}, {"Citation": "Borges G\u00c1, Elias ST, da Silva SM, et al. In vitro evaluation of wound healing and antimicrobial potential of ozone therapy. Journal of Cranio-Maxillofacial Surgery. 2017;45(3):364\u2013370. doi:10.1016/j.jcms.2017.01.005", "ArticleIdList": ["10.1016/j.jcms.2017.01.005", "28169044"]}, {"Citation": "Clavo B, C\u00f3rdoba-Lan\u00fas E, Rodr\u00edguez-Esparrag\u00f3n F, et al. Effects of ozone treatment on personal protective equipment contaminated with SARS-CoV-2. Antioxidants. 2020;9:1222. doi:10.3390/antiox9121222", "ArticleIdList": ["10.3390/antiox9121222", "PMC7761685", "33287249"]}, {"Citation": "Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727\u2013733. doi:10.1056/NEJMoa2001017", "ArticleIdList": ["10.1056/NEJMoa2001017", "PMC7092803", "31978945"]}, {"Citation": "Mao P, Wu S, Li J, et al. Human alveolar epithelial type II cells in primary culture. Physiol Rep. 2015;3(2):e12288. doi:10.14814/phy2.12288", "ArticleIdList": ["10.14814/phy2.12288", "PMC4393197", "25677546"]}, {"Citation": "Fulcher ML, Randell SH. Human nasal and tracheo-bronchial respiratory epithelial cell culture. Methods Mol Biol. 2013;945:109\u2013121.", "ArticleIdList": ["23097104"]}, {"Citation": "Stevens A, Wilson I. The haematoxylins and eosin. In: Bancroft JD, Stevens A, editors. Theory and Practice of Histological Techniques. 4th ed. Hong Kong: Churchill Livingstone; 1999:99\u2013112."}, {"Citation": "Yoon JG, Yoon J, Song JY, et al. Clinical significance of a high SARS-CoV-2 viral load in the saliva. J Korean Med Sci. 2020;35(20):1\u20135. doi:10.3346/jkms.2020.35.e195", "ArticleIdList": ["10.3346/jkms.2020.35.e195", "PMC7246183", "32449329"]}, {"Citation": "Zou L, Ruan F, Huang M, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020;382(12):1177\u20131179. doi:10.1056/NEJMc2001737", "ArticleIdList": ["10.1056/NEJMc2001737", "PMC7121626", "32074444"]}, {"Citation": "Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270\u2013273. doi:10.1038/s41586-020-2012-7", "ArticleIdList": ["10.1038/s41586-020-2012-7", "PMC7095418", "32015507"]}, {"Citation": "Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450\u2013454. doi:10.1038/nature02145", "ArticleIdList": ["10.1038/nature02145", "PMC7095016", "14647384"]}, {"Citation": "Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271\u2013280.e8. doi:10.1016/j.cell.2020.02.052", "ArticleIdList": ["10.1016/j.cell.2020.02.052", "PMC7102627", "32142651"]}, {"Citation": "Matsuyama S, et al. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. J Virol. 2010;84:12658\u201312664. doi:10.1128/JVI.01542-10", "ArticleIdList": ["10.1128/JVI.01542-10", "PMC3004351", "20926566"]}, {"Citation": "Iwata-Yoshikawa N, Okamura T, Shimizu Y, Hasegawa H, Takeda M, Nagata N. TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection. J Virol. 2019;93. doi:10.1128/JVI.01815-18", "ArticleIdList": ["10.1128/JVI.01815-18", "PMC6401451", "30626688"]}, {"Citation": "Sungnak W, Huang N, B\u00e9cavin C, et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020;26:681\u2013687. doi:10.1038/s41591-020-0868-6", "ArticleIdList": ["10.1038/s41591-020-0868-6", "PMC8637938", "32327758"]}, {"Citation": "Zhong M, Lin B, Pathak JL, et al. ACE2 and furin expressions in oral epithelial cells possibly facilitate COVID-19 infection via respiratory and fecal-oral routes. Front Med. 2020;7:580796. doi:10.3389/fmed.2020.580796", "ArticleIdList": ["10.3389/fmed.2020.580796", "PMC7758442", "33363183"]}, {"Citation": "Singapore Standards Council. Standard Guide for Accelerated Aging of Sterile Barrier Systems for Medical Devices. Enterprise Singapore; 2020."}, {"Citation": "He X, Lau EHY, Wu P, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020;26(5):672\u2013675. doi:10.1038/s41591-020-0869-5", "ArticleIdList": ["10.1038/s41591-020-0869-5", "32296168"]}, {"Citation": "Ramalingam S, Graham C, Dove J, Morrice L, Sheikh A. A pilot, open labelled, randomised controlled trial of hypertonic saline nasal irrigation and gargling for the common cold. Sci Rep. 2019;9(1):1\u20139. doi:10.1038/s41598-018-37703-3", "ArticleIdList": ["10.1038/s41598-018-37703-3", "PMC6355924", "30705369"]}, {"Citation": "Rabago D, Zgierska A. Saline nasal irrigation for upper respiratory conditions. Am Fam Phys. 2009;80(10):1117\u20131119.", "ArticleIdList": ["PMC2778074", "19904896"]}, {"Citation": "Chatterjee U, Chakraborty A, Naskar S, Saha B, Bandyapadhyay B, Shee S. Efficacy of normal saline nasal spray and gargle on SARS-CoV-2 for prevention of COVID-19 pneumonia. Res Sq. 2021;1\u20137. doi:10.21203/rs.3.rs-153598/v2", "ArticleIdList": ["10.21203/rs.3.rs-153598/v2"]}, {"Citation": "Ludwig M, Enzenhofer E, Schneider S, et al. Efficacy of a Carrageenan nasal spray in patients with common cold: a randomized controlled trial. Respir Res. 2013;14(1):124. doi:10.1186/1465-9921-14-124", "ArticleIdList": ["10.1186/1465-9921-14-124", "PMC3840586", "24219370"]}, {"Citation": "Giarratana N, Rajan B, Kamala K, Mendenhall M, Reiner G. A sprayable acid-oxidizing solution containing hypochlorous acid (AOS2020) efficiently and safely inactivates SARS-Cov-2: a new potential solution for upper respiratory tract hygiene. Eur Arch Otorhinolaryngol. 2021:1\u20135. doi:10.1007/s00405-020-06112-6", "ArticleIdList": ["10.1007/s00405-020-06112-6", "PMC7877500", "33575830"]}, {"Citation": "Shmuel K, Dalia M, Tair L, Yaakov N. Low pH Hypromellose (Taffix) nasal powder spray could reduce SARS-CoV-2 infection rate post mass-gathering event at a highly endemic community: an observational prospective open label user survey. Expert Rev Anti Infect Ther. 2021;19:1325\u20131330.", "ArticleIdList": ["PMC8022337", "33759682"]}, {"Citation": "Anderson DE, Sivalingam V, Kang AEZ, et al. Povidone-iodine demonstrates rapid in vitro virucidal activity against SARS-CoV-2, the virus causing COVID-19 disease. Infect Dis Ther. 2020;9(3):669\u2013675. doi:10.1007/s40121-020-00316-3", "ArticleIdList": ["10.1007/s40121-020-00316-3", "PMC7341475", "32643111"]}, {"Citation": "PVP-I nasal sprays and SARS-CoV-2 nasopharyngeal titers (for COVID-19) - full text view - ClinicalTrials.gov. Clinical Trials; 2021."}, {"Citation": "Braga SS. Cyclodextrins: emerging medicines of the new millennium. Biomolecules. 2019;9(12):801. doi:10.3390/biom9120801", "ArticleIdList": ["10.3390/biom9120801", "PMC6995511", "31795222"]}, {"Citation": "Ergoren MC, Paolacci S, Manara E, et al. A pilot study on the preventative potential of alpha-cyclodextrin and hydroxytyrosol against SARS-CoV-2 transmission. Acta Biomed. 2020;91(Supplement 13):e2020022. doi:10.23750/abm.v91i13-S.10817", "ArticleIdList": ["10.23750/abm.v91i13-S.10817", "PMC8023124", "33170176"]}, {"Citation": "Carrouel F, Gon\u00e7alves L, Conte M, et al. Antiviral activity of reagents in mouth rinses against SARS-CoV-2. J Dent Res. 2020;100(2):124\u2013132. doi:10.1177/0022034520967933", "ArticleIdList": ["10.1177/0022034520967933", "PMC7582358", "33089717"]}, {"Citation": "Alta\u015f B, Ko\u00e7ak H, Slt\u0131nay S, Y\u00fccaba\u015f K, Ta\u015fk\u0131n M, Oktay F. Is ozone (O3) treatment effective in atrophic rhinitis: experimental animal study. Otolaryngol Polska. 2018;72(5):37\u201344. doi:10.5604/01.3001.0012.1265", "ArticleIdList": ["10.5604/01.3001.0012.1265", "30460908"]}, {"Citation": "Shah M, Captain J, Vaidya V, et al. Safety and efficacy of ozone therapy in mild to moderate COVID-19 patients: a phase 1/11 randomized control trial (SEOT study). Int Immunopharmacol. 2021;91:107301. doi:10.1016/j.intimp.2020.107301", "ArticleIdList": ["10.1016/j.intimp.2020.107301", "PMC7758022", "33421928"]}, {"Citation": "Cattel F, Giordano S, Bertiond C, et al. Ozone therapy in COVID-19: a narrative review. Virus Res. 2021;291:198207. doi:10.1016/j.virusres.2020.198207", "ArticleIdList": ["10.1016/j.virusres.2020.198207", "PMC7585733", "33115670"]}, {"Citation": "Tizaoui C. Ozone: a potential oxidant for COVID-19 virus (SARSCoV-2). Ozone Sci Eng. 2020;42(5):378\u2013385. doi:10.1080/01919512.2020.1795614", "ArticleIdList": ["10.1080/01919512.2020.1795614"]}, {"Citation": "Casale M, Moffa A, Sabatino L, et al. Hyaluronic acid: perspectives in upper aero-digestive tract. A systematic review. PLoS One. 2015;10(6):e0130637. doi:10.1371/journal.pone.0130637", "ArticleIdList": ["10.1371/journal.pone.0130637", "PMC4487693", "26120837"]}, {"Citation": "M\u00f6sges R, Baena-Cagnani CE, Passali D. Nonpharmacological treatment of rhinoconjunctivitis and rhinosinusitis. J Allergy. 2014;(2014:1\u20132. doi:10.1155/2014/416236", "ArticleIdList": ["10.1155/2014/416236", "PMC4283391", "25587288"]}, {"Citation": "El Kechai N, Geiger S, Fallacara A, et al. Mixtures of hyaluronic acid and liposomes for drug delivery: phase behavior, microstructure and mobility of liposomes. Int J Pharm. 2017;523(1):246\u2013259. doi:10.1016/j.ijpharm.2017.03.029", "ArticleIdList": ["10.1016/j.ijpharm.2017.03.029", "28323101"]}, {"Citation": "Arpicco S, Lerda C, Dalla Pozza E, et al. Hyaluronic acid-coated liposomes for active targeting of gemcitabine. hyaluronic acid-coated liposomes for active targeting of gemcitabine. Eur J Pharm Biopharm. 2013;85:373\u2013380. doi:10.1016/j.ejpb.2013.06.003", "ArticleIdList": ["10.1016/j.ejpb.2013.06.003", "23791684"]}, {"Citation": "Danaei M, Dehghankhold M, Ataei S, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10:57. doi:10.3390/pharmaceutics10020057", "ArticleIdList": ["10.3390/pharmaceutics10020057", "PMC6027495", "29783687"]}, {"Citation": "Schreiner TB, Santamaria-Echart A, Ribeiro A, et al. Formulation and optimization of nanoemulsions using the natural surfactant saponin from quillaja bark. Molecules. 2020b;25(7):1538. doi:10.3390/molecules25071538", "ArticleIdList": ["10.3390/molecules25071538", "PMC7181021", "32230976"]}, {"Citation": "Creech, C. B., Walker, S. C., & Samuels, R. J. SARS-CoV-2 Vaccines.\u00a0JAMA,\u00a02021; 325(13), 1318. doi:10.1001/jama.2021.3199", "ArticleIdList": ["10.1001/jama.2021.3199", "33635317"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "7", "Day": "10"}, {"Year": "2021", "Month": "12", "Day": "24"}, {"Year": "2022", "Month": "2", "Day": "4", "Hour": "5", "Minute": "47"}, {"Year": "2022", "Month": "2", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "25"}], "PublicationStatus": "epublish", "ArticleIdList": ["35115773", "PMC8801396", "10.2147/IJN.S328090", "328090"]}}], "PubmedBookArticle": []}